EP1349548A4 - Verfahren und zusammensetzungen zur behandlung von parodontose - Google Patents
Verfahren und zusammensetzungen zur behandlung von parodontoseInfo
- Publication number
- EP1349548A4 EP1349548A4 EP01994350A EP01994350A EP1349548A4 EP 1349548 A4 EP1349548 A4 EP 1349548A4 EP 01994350 A EP01994350 A EP 01994350A EP 01994350 A EP01994350 A EP 01994350A EP 1349548 A4 EP1349548 A4 EP 1349548A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- compositions
- methods
- periodontal disease
- treating periodontal
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Furan Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25944101P | 2001-01-03 | 2001-01-03 | |
US259441P | 2001-01-03 | ||
PCT/US2001/049638 WO2002053099A2 (en) | 2001-01-03 | 2001-12-28 | Methods and compositions for treating periodontal disease |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1349548A2 EP1349548A2 (de) | 2003-10-08 |
EP1349548A4 true EP1349548A4 (de) | 2004-06-02 |
Family
ID=22984959
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP01994350A Ceased EP1349548A4 (de) | 2001-01-03 | 2001-12-28 | Verfahren und zusammensetzungen zur behandlung von parodontose |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1349548A4 (de) |
JP (1) | JP2004517853A (de) |
AU (1) | AU2002246757B2 (de) |
CA (1) | CA2432504A1 (de) |
WO (1) | WO2002053099A2 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201305668D0 (en) | 2013-03-28 | 2013-05-15 | Glaxosmithkline Ip Dev Ltd | Avs6 Integrin Antagonists |
PT3929196T (pt) | 2013-09-24 | 2023-09-11 | Fujifilm Corp | Composição farmacêutica de um novo composto contendo azoto ou seu sal, ou seu complexo de metal |
GB201417002D0 (en) | 2014-09-26 | 2014-11-12 | Glaxosmithkline Ip Dev Ltd | Novel compound |
GB201417011D0 (en) | 2014-09-26 | 2014-11-12 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
GB201417094D0 (en) | 2014-09-26 | 2014-11-12 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
GB201417018D0 (en) | 2014-09-26 | 2014-11-12 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
GB201604680D0 (en) | 2016-03-21 | 2016-05-04 | Glaxosmithkline Ip Dev Ltd | Chemical Compounds |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999031099A1 (en) * | 1997-12-17 | 1999-06-24 | Merck & Co., Inc. | Integrin receptor antagonists |
US6017926A (en) * | 1997-12-17 | 2000-01-25 | Merck & Co., Inc. | Integrin receptor antagonists |
WO2000006169A1 (en) * | 1998-07-29 | 2000-02-10 | Merck & Co., Inc. | Integrin receptor antagonists |
US6048861A (en) * | 1997-12-17 | 2000-04-11 | Merck & Co., Inc. | Integrin receptor antagonists |
WO2000072801A2 (en) * | 1999-06-02 | 2000-12-07 | Merck & Co., Inc. | Alpha v integrin receptor antagonists |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5190981A (en) * | 1989-08-17 | 1993-03-02 | Sepracor Inc. | Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease |
US20020028798A1 (en) * | 1995-12-12 | 2002-03-07 | Omeros Medical Systems | Irrigation solution and method for inhibition of pain and inflammation |
US6136804A (en) * | 1998-03-13 | 2000-10-24 | Merck & Co., Inc. | Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions |
-
2001
- 2001-12-28 EP EP01994350A patent/EP1349548A4/de not_active Ceased
- 2001-12-28 WO PCT/US2001/049638 patent/WO2002053099A2/en active IP Right Grant
- 2001-12-28 AU AU2002246757A patent/AU2002246757B2/en not_active Ceased
- 2001-12-28 CA CA002432504A patent/CA2432504A1/en not_active Abandoned
- 2001-12-28 JP JP2002554050A patent/JP2004517853A/ja not_active Withdrawn
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999031099A1 (en) * | 1997-12-17 | 1999-06-24 | Merck & Co., Inc. | Integrin receptor antagonists |
US6017926A (en) * | 1997-12-17 | 2000-01-25 | Merck & Co., Inc. | Integrin receptor antagonists |
US6048861A (en) * | 1997-12-17 | 2000-04-11 | Merck & Co., Inc. | Integrin receptor antagonists |
WO2000006169A1 (en) * | 1998-07-29 | 2000-02-10 | Merck & Co., Inc. | Integrin receptor antagonists |
WO2000072801A2 (en) * | 1999-06-02 | 2000-12-07 | Merck & Co., Inc. | Alpha v integrin receptor antagonists |
Non-Patent Citations (1)
Title |
---|
See also references of WO02053099A3 * |
Also Published As
Publication number | Publication date |
---|---|
WO2002053099A2 (en) | 2002-07-11 |
WO2002053099A3 (en) | 2002-09-12 |
AU2002246757B2 (en) | 2006-02-02 |
EP1349548A2 (de) | 2003-10-08 |
CA2432504A1 (en) | 2002-07-11 |
JP2004517853A (ja) | 2004-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL160933A0 (en) | Methods and compositions for treating ?cap associated diseases | |
HK1089364A1 (en) | Topical compositions and methods for treating pain | |
EP1446114A4 (de) | Zusammensetzungen und verfahren zur behandlung von osteoporose | |
AU2002357119A8 (en) | Mitocidal compositions and methods | |
EP1416961A4 (de) | Zusammensetzung und verfahren zur behandlung von krankheiten | |
GB0110288D0 (en) | Composition and treatment method | |
AU2002243023A1 (en) | Compositions for preventing and/or treating oral diseases | |
EP1438062A4 (de) | Verfahren und zusammensetzungen zur behandlung von hautläsionen | |
EP1572118A4 (de) | Verfahren und zusammensetzungen zur behandlung von krebs mit 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 216 | |
HUP0400609A3 (en) | Wet-skin treatment compositions | |
EP1461047A4 (de) | Zusammensetzungen und verfahren zur behandlung von tieren | |
AU2002357748A8 (en) | Osteopontin-related compositions and methods | |
GB0012061D0 (en) | Hair treatment compositions | |
GB0126643D0 (en) | Composition and process | |
EP1349548A4 (de) | Verfahren und zusammensetzungen zur behandlung von parodontose | |
AU2003259202A8 (en) | Compositions and methods for treating and preventing infection | |
AU2003275433A8 (en) | Compositions and methods for treating pain | |
EP1261331A4 (de) | Methoden und zusammenstellungen zur behandlung von fibrotischen erkrankungen | |
AU2002342188A8 (en) | Methods and compositions for treating flavivirus-mediated disease | |
AU2002353915A1 (en) | Methods and compositions for treating rotavirus-mediated disease | |
AU2002359869A8 (en) | Pak5-related compositions and methods | |
GB0000556D0 (en) | Malodour treatment compositions | |
GB0012064D0 (en) | Hair treatment compositions | |
EP1397507A4 (de) | Verfahren und zusammensetzungen zur behandlung einer kardiovaskulären erkrankung mit 10218 | |
IL159333A0 (en) | Plant treatment composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20030804 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20040421 |
|
17Q | First examination report despatched |
Effective date: 20040824 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20060101 |